Cargando…

Targeting Signaling Pathways in Inflammatory Breast Cancer

SIMPLE SUMMARY: Inflammatory breast cancer (IBC) is the most lethal and aggressive form of breast cancer; it is highly likely to spread to other sites in the body. There is an urgent need to establish novel treatment strategies to reduce IBC recurrence and metastasis. The aim of this work is to prov...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xiaoping, Semba, Takashi, Phi, Lan Thi Hanh, Chainitikun, Sudpreeda, Iwase, Toshiaki, Lim, Bora, Ueno, Naoto T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563157/ https://www.ncbi.nlm.nih.gov/pubmed/32883032 http://dx.doi.org/10.3390/cancers12092479

Ejemplares similares

Update on systemic treatment for newly diagnosed inflammatory breast cancer
por: Chainitikun, Sudpreeda, et al.
Publicado: (2020)

Pathological complete response of adding targeted therapy to neoadjuvant chemotherapy for inflammatory breast cancer: A systematic review
por: Chainitikun, Sudpreeda, et al.
Publicado: (2021)

Validation of Prognostic Stage and Anatomic Stage in the American Joint Committee on Cancer 8th Edition for Inflammatory Breast Cancer
por: Kida, Kumiko, et al.
Publicado: (2020)

The Prognostic Impact of Body Composition for Locally Advanced Breast Cancer Patients Who Received Neoadjuvant Chemotherapy
por: Iwase, Toshiaki, et al.
Publicado: (2021)

EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer
por: Wang, Xiaoping, et al.
Publicado: (2022)

Comparison of molecular profile in triple-negative inflammatory and non-inflammatory breast cancer not of mesenchymal stem-like subtype
por: Funakoshi, Yohei, et al.
Publicado: (2019)

PI3K and MAPK Pathways as Targets for Combination with the Pan-HER Irreversible Inhibitor Neratinib in HER2-Positive Breast Cancer and TNBC by Kinome RNAi Screening
por: Lee, Jangsoon, et al.
Publicado: (2021)

JNK Signaling in Stem Cell Self-Renewal and Differentiation
por: Semba, Takashi, et al.
Publicado: (2020)

Inflammatory breast cancer biomarker identification by simultaneous TGIRT-seq profiling of coding and non-coding RNAs in tumors and blood
por: Wylie, Dennis, et al.
Publicado: (2023)

Hedgehog Signaling in Cancer: A Prospective Therapeutic Target for Eradicating Cancer Stem Cells
por: Sari, Ita Novita, et al.
Publicado: (2018)

A target of potential RELAvance in inflammatory breast cancer
por: Eckhardt, Bedrich L., et al.
Publicado: (2017)

Identification of Kinase Targets for Enhancing the Antitumor Activity of Eribulin in Triple-Negative Breast Cell Lines
por: Xie, Xuemei, et al.
Publicado: (2023)

Reassessing Estrogen Receptor Expression Thresholds for Breast Cancer Prognosis in HER2-negative Patients Using Shape Restricted Modeling
por: Dong, Wenli, et al.
Publicado: (2023)

NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non‐inflammatory breast cancers
por: Bertucci, François, et al.
Publicado: (2020)

Changes in Overall Survival over Time for Patients with de novo Metastatic Breast Cancer
por: Iwase, Toshiaki, et al.
Publicado: (2021)

Targeting EGFR in Triple Negative Breast Cancer
por: Ueno, Naoto T., et al.
Publicado: (2011)

Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBC
por: Iwase, Toshiaki, et al.
Publicado: (2020)

EGFR signaling promotes inflammation and cancer stem-like activity in inflammatory breast cancer
por: Wang, Xiaoping, et al.
Publicado: (2017)

Phase II study of Radium‐223 dichloride combined with hormonal therapy for hormone receptor‐positive, bone‐dominant metastatic breast cancer
por: Ueno, Naoto T., et al.
Publicado: (2019)

20(R)-Ginsenoside Rg3 Influences Cancer Stem Cell Properties and the Epithelial-Mesenchymal Transition in Colorectal Cancer via the SNAIL Signaling Axis
por: Phi, Lan Thi Hanh, et al.
Publicado: (2019)

Microorganism-Derived Molecules as Enzyme Inhibitors to Target Alzheimer’s Diseases Pathways
por: Nguyen, Thi Hanh, et al.
Publicado: (2023)

Editorial: Targeting signalling pathways in inflammatory diseases
por: Baig, Mirza S., et al.
Publicado: (2023)

Decorin-mediated suppression of tumorigenesis, invasion, and metastasis in inflammatory breast cancer
por: Hu, Xiaoding, et al.
Publicado: (2021)

Stabilization of E-cadherin adhesions by COX-2/GSK3β signaling is a targetable pathway in metastatic breast cancer
por: Balamurugan, Kuppusamy, et al.
Publicado: (2023)

Bone metastasis-related signaling pathways in breast cancers stratified by estrogen receptor status
por: Hayashi, Naoki, et al.
Publicado: (2017)

Survivorship and Advocacy in Inflammatory Breast Cancer
por: Alexander, Angela, et al.
Publicado: (2018)

Targeting the Notch Signaling Pathway in Chronic Inflammatory Diseases
por: Christopoulos, Panagiotis F., et al.
Publicado: (2021)

The Relationship Between Skeletal-Related Events and Bone Scan Index for the Treatment of Bone Metastasis With Breast Cancer Patients
por: Iwase, Toshiaki, et al.
Publicado: (2014)

The anti‐metastatic effect of ginsenoside Rb2 in colorectal cancer in an EGFR/SOX2‐dependent manner
por: Phi, Lan Thi Hanh, et al.
Publicado: (2018)

International Consensus on the Clinical Management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary Conference
por: Ueno, Naoto T., et al.
Publicado: (2018)

Effects of nano-copper on maize yield and inflammatory response in mice
por: Hien, Le Thi Thu, et al.
Publicado: (2019)

ONC201 and an MEK Inhibitor Trametinib Synergistically Inhibit the Growth of Triple-Negative Breast Cancer Cells
por: Lim, Bora, et al.
Publicado: (2021)

Interferon-induced transmembrane protein 1 (IFITM1) is required for the progression of colorectal cancer
por: Sari, Novita Ita, et al.
Publicado: (2016)

A Novel Immunomodulatory 27-Gene Signature to Predict Response to Neoadjuvant Immunochemotherapy for Primary Triple-Negative Breast Cancer
por: Iwase, Toshiaki, et al.
Publicado: (2021)

Is the future of personalized therapy in triple-negative breast cancer based on molecular subtype?
por: Le Du, Fanny, et al.
Publicado: (2015)

Characterization and Targeting of Platelet-Derived Growth Factor Receptor alpha (PDGFRA) in Inflammatory Breast Cancer (IBC)()
por: Joglekar-Javadekar, Madhura, et al.
Publicado: (2017)

The influence of twist angle on the electronic and phononic band of 2D twisted bilayer SiC
por: Nguyen, Hoa Van, et al.
Publicado: (2023)

Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasion
por: Villodre, Emilly S., et al.
Publicado: (2021)

Membrane Hormone Receptors and Their Signaling Pathways as Targets for Endocrine Disruptors
por: Combarnous, Yves, et al.
Publicado: (2022)

The Hedgehog Signaling Pathway: A Viable Target in Breast Cancer?
por: Bhateja, Priyanka, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bae1hafeseeq1549ffj7nvh3gk